FDA Clarifies Approach To Pediatric Drug Development - Life Sciences, Biotechnology & Nanotechnology
On May 17, the U.S. Food & Drug Administration ("FDA") issued two important draft guidance documents, which clarify the agency's approach to requirements and incentives in the realm of pediatric drug development...